Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

HLN vs KVUE vs PG vs CL vs KMB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HLN
Haleon plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • GB
Market Cap$41.45B
5Y Perf.+15.8%
KVUE
Kenvue Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$34.06B
5Y Perf.-29.3%
PG
The Procter & Gamble Company

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$341.30B
5Y Perf.+2.5%
CL
Colgate-Palmolive Company

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$70.09B
5Y Perf.+17.5%
KMB
Kimberly-Clark Corporation

Household & Personal Products

Consumer DefensiveNASDAQ • US
Market Cap$33.05B
5Y Perf.-25.9%

HLN vs KVUE vs PG vs CL vs KMB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HLN logoHLN
KVUE logoKVUE
PG logoPG
CL logoCL
KMB logoKMB
IndustryDrug Manufacturers - Specialty & GenericHousehold & Personal ProductsHousehold & Personal ProductsHousehold & Personal ProductsHousehold & Personal Products
Market Cap$41.45B$34.06B$341.30B$70.09B$33.05B
Revenue (TTM)$22.01B$15.29B$86.72B$20.38B$16.54B
Net Income (TTM)$3.18B$1.62B$12.72B$2.13B$2.12B
Gross Margin63.9%58.4%50.3%60.1%35.9%
Operating Margin21.4%19.0%23.2%21.3%13.3%
Forward P/E22.2x15.6x21.1x22.9x13.2x
Total Debt$8.59B$8.52B$35.46B$7.99B$7.17B
Cash & Equiv.$1.32B$1.06B$9.56B$1.29B$688M

HLN vs KVUE vs PG vs CL vs KMBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HLN
KVUE
PG
CL
KMB
StockMay 23May 26Return
Haleon plc (HLN)100115.8+15.8%
Kenvue Inc. (KVUE)10070.7-29.3%
The Procter & Gambl… (PG)100102.5+2.5%
Colgate-Palmolive C… (CL)100117.5+17.5%
Kimberly-Clark Corp… (KMB)10074.1-25.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: HLN vs KVUE vs PG vs CL vs KMB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CL leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and recent price momentum and sentiment. Haleon plc is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. PG also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
HLN
Haleon plc
The Defensive Pick

HLN is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.

  • Lower volatility, beta 0.06, Low D/E 52.2%, current ratio 0.92x
  • PEG 2.63 vs PG's 3.78
  • Beta 0.06, yield 1.9%, current ratio 0.92x
  • Lower P/E (22.2x vs 22.9x)
Best for: sleep-well-at-night and valuation efficiency
KVUE
Kenvue Inc.
The Income Angle

KVUE lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: consumer defensive exposure
PG
The Procter & Gamble Company
The Long-Run Compounder

PG ranks third and is worth considering specifically for long-term compounding.

  • 119.3% 10Y total return vs HLN's 31.7%
  • 14.7% margin vs CL's 10.5%
  • 2.8% yield, 36-year raise streak, vs KMB's 5.0%
Best for: long-term compounding
CL
Colgate-Palmolive Company
The Growth Play

CL carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 1.4%, EPS growth -25.1%, 3Y rev CAGR 4.3%
  • 1.4% revenue growth vs KMB's -14.2%
  • -1.6% vs KMB's -21.7%
  • 12.5% ROA vs KVUE's 6.0%, ROIC 43.4% vs 11.4%
Best for: growth exposure
KMB
Kimberly-Clark Corporation
The Income Pick

KMB is the clearest fit if your priority is income & stability.

  • Dividend streak 27 yrs, beta 0.14, yield 5.0%
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthCL logoCL1.4% revenue growth vs KMB's -14.2%
ValueHLN logoHLNLower P/E (22.2x vs 22.9x)
Quality / MarginsPG logoPG14.7% margin vs CL's 10.5%
Stability / SafetyHLN logoHLNBeta 0.06 vs KVUE's 0.24, lower leverage
DividendsPG logoPG2.8% yield, 36-year raise streak, vs KMB's 5.0%
Momentum (1Y)CL logoCL-1.6% vs KMB's -21.7%
Efficiency (ROA)CL logoCL12.5% ROA vs KVUE's 6.0%, ROIC 43.4% vs 11.4%

HLN vs KVUE vs PG vs CL vs KMB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HLNHaleon plc
FY 2022
Respiratory Health
100.0%$1.6B
KVUEKenvue Inc.
FY 2025
Self Care
42.2%$6.4B
Essential Health
30.6%$4.6B
Skin Health and Beauty
27.2%$4.1B
PGThe Procter & Gamble Company
FY 2025
Fabric Care And Home Care Segment Member
35.5%$29.6B
Baby, Feminine and Family Care Segment Member
24.3%$20.2B
Beauty Segment
17.9%$15.0B
Health Care Segment Member
14.4%$12.0B
Grooming Segment Member
8.0%$6.7B
CLColgate-Palmolive Company
FY 2025
Oral, Personal and Home Care
77.4%$15.8B
Pet Nutrition
22.6%$4.6B
KMBKimberly-Clark Corporation
FY 2025
Diapers
41.5%$6.8B
Consumer tissue products
24.8%$4.1B
Adult care products
11.9%$1.9B
Away from Home Professional Products
11.3%$1.8B
Feminine care products
10.5%$1.7B

HLN vs KVUE vs PG vs CL vs KMB — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCLLAGGINGKVUE

Income & Cash Flow (Last 12 Months)

PG leads this category, winning 3 of 6 comparable metrics.

PG is the larger business by revenue, generating $86.7B annually — 5.7x KVUE's $15.3B. Profitability is closely matched — net margins range from 14.7% (PG) to 10.5% (CL). On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…KMB logoKMBKimberly-Clark Co…
RevenueTrailing 12 months$22.0B$15.3B$86.7B$20.4B$16.5B
EBITDAEarnings before interest/tax$5.3B$3.3B$21.9B$3.9B$2.8B
Net IncomeAfter-tax profit$3.2B$1.6B$12.7B$2.1B$2.1B
Free Cash FlowCash after capex$3.1B$1.5B$15.0B$3.6B$2.6B
Gross MarginGross profit ÷ Revenue+63.9%+58.4%+50.3%+60.1%+35.9%
Operating MarginEBIT ÷ Revenue+21.4%+19.0%+23.2%+21.3%+13.3%
Net MarginNet income ÷ Revenue+14.5%+10.6%+14.7%+10.5%+12.8%
FCF MarginFCF ÷ Revenue+14.2%+9.6%+17.3%+17.8%+15.6%
Rev. Growth (YoY)Latest quarter vs prior year-0.4%+4.5%+7.4%+5.8%-14.0%
EPS Growth (YoY)Latest quarter vs prior year+18.8%+47.1%+5.8%-105.1%+17.6%
PG leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

KMB leads this category, winning 4 of 7 comparable metrics.

At 16.4x trailing earnings, KMB trades at a 51% valuation discount to CL's 33.2x P/E. Adjusting for growth (PEG ratio), HLN offers better value at 2.25x vs PG's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…KMB logoKMBKimberly-Clark Co…
Market CapShares × price$41.4B$34.1B$341.3B$70.1B$33.0B
Enterprise ValueMkt cap + debt − cash$51.3B$41.5B$367.2B$76.8B$39.5B
Trailing P/EPrice ÷ TTM EPS19.01x23.34x22.44x33.22x16.40x
Forward P/EPrice ÷ next-FY EPS est.22.22x15.59x21.14x22.88x13.24x
PEG RatioP/E ÷ EPS growth rate2.25x4.01x
EV / EBITDAEnterprise value multiple13.62x12.73x15.76x15.43x12.73x
Price / SalesMarket cap ÷ Revenue2.83x2.25x4.05x3.44x1.92x
Price / BookPrice ÷ Book value/share1.87x3.17x6.86x194.13x20.07x
Price / FCFMarket cap ÷ FCF15.47x19.78x24.30x19.29x20.16x
KMB leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

CL leads this category, winning 4 of 9 comparable metrics.

CL delivers a 2.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $15 for KVUE. HLN carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs KMB's 5/9, reflecting strong financial health.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…KMB logoKMBKimberly-Clark Co…
ROE (TTM)Return on equity+19.9%+15.2%+23.8%+2.5%+131.7%
ROA (TTM)Return on assets+10.0%+6.0%+10.0%+12.5%+12.5%
ROICReturn on invested capital+7.6%+11.4%+20.1%+43.4%+23.3%
ROCEReturn on capital employed+8.6%+13.2%+23.0%+41.6%+25.3%
Piotroski ScoreFundamental quality 0–986565
Debt / EquityFinancial leverage0.52x0.79x0.68x21.88x4.34x
Net DebtTotal debt minus cash$7.3B$7.5B$25.9B$6.7B$6.5B
Cash & Equiv.Liquid assets$1.3B$1.1B$9.6B$1.3B$688M
Total DebtShort + long-term debt$8.6B$8.5B$35.5B$8.0B$7.2B
Interest CoverageEBIT ÷ Interest expense7.80x4.68x487.21x12.37x9.67x
CL leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CL leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HLN five years ago would be worth $13,169 today (with dividends reinvested), compared to $7,428 for KVUE. Over the past 12 months, CL leads with a -1.6% total return vs KMB's -21.7%. The 3-year compound annual growth rate (CAGR) favors CL at 5.0% vs KVUE's -9.0% — a key indicator of consistent wealth creation.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…KMB logoKMBKimberly-Clark Co…
YTD ReturnYear-to-date-5.6%+3.6%+4.5%+13.8%-0.6%
1-Year ReturnPast 12 months-11.7%-19.7%-5.6%-1.6%-21.7%
3-Year ReturnCumulative with dividends+10.4%-24.6%+1.9%+15.7%-21.0%
5-Year ReturnCumulative with dividends+31.7%-25.7%+22.4%+18.2%-8.8%
10-Year ReturnCumulative with dividends+31.7%-25.7%+119.3%+47.0%+12.2%
CAGR (3Y)Annualised 3-year return+3.4%-9.0%+0.6%+5.0%-7.6%
CL leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

CL leads this category, winning 2 of 2 comparable metrics.

CL is the less volatile stock with a -0.00 beta — it tends to amplify market swings less than KVUE's 0.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CL currently trades 87.9% from its 52-week high vs KMB's 69.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…KMB logoKMBKimberly-Clark Co…
Beta (5Y)Sensitivity to S&P 5000.06x0.24x0.10x-0.00x0.14x
52-Week HighHighest price in past year$11.42$25.17$170.99$99.33$144.31
52-Week LowLowest price in past year$8.71$14.02$137.62$74.55$92.42
% of 52W HighCurrent price vs 52-week peak+81.5%+70.5%+85.4%+87.9%+69.0%
RSI (14)Momentum oscillator 0–10036.054.853.758.153.7
Avg Volume (50D)Average daily shares traded8.0M19.5M7.2M5.6M4.7M
CL leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — PG and KMB each lead in 1 of 2 comparable metrics.

Analyst consensus: HLN as "Buy", KVUE as "Hold", PG as "Buy", CL as "Hold", KMB as "Hold". Consensus price targets imply 10.8% upside for PG (target: $162) vs 2.9% for KVUE (target: $18). For income investors, KMB offers the higher dividend yield at 5.01% vs HLN's 1.94%.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…KMB logoKMBKimberly-Clark Co…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyHoldHold
Price TargetConsensus 12-month target$10.20$18.25$161.88$93.70$110.00
# AnalystsCovering analysts414524531
Dividend YieldAnnual dividend ÷ price+1.9%+4.6%+2.8%+2.6%+5.0%
Dividend StreakConsecutive years of raises2136527
Dividend / ShareAnnual DPS$0.13$0.82$4.02$2.25$4.98
Buyback YieldShare repurchases ÷ mkt cap+2.1%+0.6%+1.9%+1.7%+0.4%
Evenly matched — PG and KMB each lead in 1 of 2 comparable metrics.
Key Takeaway

CL leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). PG leads in 1 (Income & Cash Flow). 1 tied.

Best OverallColgate-Palmolive Company (CL)Leads 3 of 6 categories
Loading custom metrics...

HLN vs KVUE vs PG vs CL vs KMB: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is HLN or KVUE or PG or CL or KMB a better buy right now?

For growth investors, Colgate-Palmolive Company (CL) is the stronger pick with 1.

4% revenue growth year-over-year, versus -14. 2% for Kimberly-Clark Corporation (KMB). Kimberly-Clark Corporation (KMB) offers the better valuation at 16. 4x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HLN or KVUE or PG or CL or KMB?

On trailing P/E, Kimberly-Clark Corporation (KMB) is the cheapest at 16.

4x versus Colgate-Palmolive Company at 33. 2x. On forward P/E, Kimberly-Clark Corporation is actually cheaper at 13. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Haleon plc wins at 2. 63x versus The Procter & Gamble Company's 3. 78x.

03

Which is the better long-term investment — HLN or KVUE or PG or CL or KMB?

Over the past 5 years, Haleon plc (HLN) delivered a total return of +31.

7%, compared to -25. 7% for Kenvue Inc. (KVUE). Over 10 years, the gap is even starker: PG returned +119. 3% versus KVUE's -25. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HLN or KVUE or PG or CL or KMB?

By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.

00β versus Kenvue Inc. 's 0. 24β — meaning KVUE is approximately -5618% more volatile than CL relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — HLN or KVUE or PG or CL or KMB?

By revenue growth (latest reported year), Colgate-Palmolive Company (CL) is pulling ahead at 1.

4% versus -14. 2% for Kimberly-Clark Corporation (KMB). On earnings-per-share growth, the picture is similar: Kenvue Inc. grew EPS 40. 7% year-over-year, compared to -25. 1% for Colgate-Palmolive Company. Over a 3-year CAGR, CL leads at 4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HLN or KVUE or PG or CL or KMB?

The Procter & Gamble Company (PG) is the more profitable company, earning 19.

0% net margin versus 9. 7% for Kenvue Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 14. 5% for KMB. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HLN or KVUE or PG or CL or KMB more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Haleon plc (HLN) is the more undervalued stock at a PEG of 2. 63x versus The Procter & Gamble Company's 3. 78x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Kimberly-Clark Corporation (KMB) trades at 13. 2x forward P/E versus 22. 9x for Colgate-Palmolive Company — 9. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 10. 8% to $161. 88.

08

Which pays a better dividend — HLN or KVUE or PG or CL or KMB?

All stocks in this comparison pay dividends.

Kimberly-Clark Corporation (KMB) offers the highest yield at 5. 0%, versus 1. 9% for Haleon plc (HLN).

09

Is HLN or KVUE or PG or CL or KMB better for a retirement portfolio?

For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

00), 2. 6% yield). Both have compounded well over 10 years (CL: +47. 0%, KVUE: -25. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HLN and KVUE and PG and CL and KMB?

These companies operate in different sectors (HLN (Healthcare) and KVUE (Consumer Defensive) and PG (Consumer Defensive) and CL (Consumer Defensive) and KMB (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLN is a mid-cap quality compounder stock; KVUE is a mid-cap income-oriented stock; PG is a large-cap quality compounder stock; CL is a mid-cap quality compounder stock; KMB is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

HLN

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.7%
Run This Screen
Stocks Like

KVUE

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 6%
  • Dividend Yield > 1.8%
Run This Screen
Stocks Like

PG

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

CL

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Stocks Like

KMB

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 2.0%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HLN and KVUE and PG and CL and KMB on the metrics below

Revenue Growth>
%
(HLN: -0.4% · KVUE: 4.5%)
Net Margin>
%
(HLN: 14.5% · KVUE: 10.6%)
P/E Ratio<
x
(HLN: 19.0x · KVUE: 23.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.